Carisma Therapeutics to Participate in the Stifel 2024 Cell Therapy Forum

Core Insights - Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies using a proprietary macrophage and monocyte cell engineering platform [5] Company Participation - Steven Kelly, President and CEO of Carisma, will participate in a fireside chat at the Stifel 2024 Cell Therapy Forum on July 9th at 9:10 am ET [1] Event Details - An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event [4]